The first quarter is in the books, and the S&P 500’s best and worst performers are a pharmacy chain and a footwear ...

In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...

CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the just-concluded quarter ...

And concerning the all-star performers, Philip Morris PM, CVS Health CVS, and Newmont NEM all reflect top-performing S&P 500 stocks ... the stock’s strong YTD performance, up nearly 30%.

Waters shares tumbled 5.8% on Wednesday. The top performance in the S&P 500 Wednesday came from shares of CVS Health (CVS), which surged 14.9% after the pharmacy operator and health insurance ...

Q1’s top S&P 500 performers held strong despite tariffs ... Analyst consensus shows only Newmont and CVS have potential upside of 25.8% and 13.2%, respectively, based on median price targets.

Year to date, the S&P 500 is now down nearly 4.5%, and many investors are worried that there could be further declines coming. The best-performing stock on this list is CVS Health, which has risen ...

In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the ...